Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbx15
|
ENSMUSG00000027868.5 | T-box 15 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_99254941_99255092 | Tbx15 | 1256 | 0.408722 | -0.55 | 1.6e-05 | Click! |
chr3_99253571_99254140 | Tbx15 | 95 | 0.962997 | -0.54 | 1.9e-05 | Click! |
chr3_99234378_99234529 | Tbx15 | 5928 | 0.155213 | -0.54 | 2.1e-05 | Click! |
chr3_99252944_99253095 | Tbx15 | 741 | 0.616044 | -0.37 | 5.6e-03 | Click! |
chr3_99312131_99312282 | Tbx15 | 15696 | 0.197301 | -0.30 | 2.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_174347204_174348264 | 78.77 |
Gm20721 |
predicted gene, 20721 |
1022 |
0.44 |
chr10_127508848_127510720 | 31.90 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr4_46407004_46407329 | 22.05 |
Hemgn |
hemogen |
2930 |
0.18 |
chr6_88758260_88758436 | 21.94 |
Gm43999 |
predicted gene, 43999 |
15621 |
0.11 |
chr6_124919273_124920636 | 20.21 |
Ptms |
parathymosin |
149 |
0.88 |
chr12_103956494_103956864 | 19.78 |
Serpina1e |
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
219 |
0.88 |
chr4_46404152_46404582 | 18.26 |
Hemgn |
hemogen |
131 |
0.94 |
chr3_103171228_103172264 | 18.21 |
Bcas2 |
breast carcinoma amplified sequence 2 |
3 |
0.97 |
chr8_122174592_122174743 | 17.62 |
Zfp469 |
zinc finger protein 469 |
83953 |
0.07 |
chr6_122826008_122826698 | 17.46 |
Foxj2 |
forkhead box J2 |
322 |
0.79 |
chr2_146099017_146099372 | 16.81 |
Cfap61 |
cilia and flagella associated protein 61 |
51943 |
0.15 |
chr12_106027461_106027735 | 16.24 |
Vrk1 |
vaccinia related kinase 1 |
1791 |
0.4 |
chr11_48873308_48874023 | 16.21 |
Irgm1 |
immunity-related GTPase family M member 1 |
1982 |
0.19 |
chr12_111353338_111354089 | 15.89 |
Cdc42bpb |
CDC42 binding protein kinase beta |
23906 |
0.13 |
chr11_94290140_94290302 | 15.87 |
Luc7l3 |
LUC7-like 3 (S. cerevisiae) |
3002 |
0.2 |
chr11_69901245_69901922 | 15.79 |
Neurl4 |
neuralized E3 ubiquitin protein ligase 4 |
233 |
0.66 |
chr14_14012273_14013624 | 15.77 |
Atxn7 |
ataxin 7 |
196 |
0.95 |
chr3_153850585_153850776 | 15.77 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
1721 |
0.2 |
chr8_122551277_122551909 | 15.57 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
264 |
0.83 |
chr2_93455310_93455482 | 15.22 |
Gm10804 |
predicted gene 10804 |
2575 |
0.23 |
chr2_119566179_119566455 | 15.12 |
Chp1 |
calcineurin-like EF hand protein 1 |
288 |
0.85 |
chr10_80576603_80578409 | 15.02 |
Klf16 |
Kruppel-like factor 16 |
185 |
0.86 |
chr19_16435353_16436213 | 14.99 |
Gna14 |
guanine nucleotide binding protein, alpha 14 |
21 |
0.98 |
chr12_91683081_91683272 | 14.92 |
Gm16876 |
predicted gene, 16876 |
1489 |
0.34 |
chr9_66158579_66158741 | 14.65 |
Dapk2 |
death-associated protein kinase 2 |
425 |
0.83 |
chr12_17505834_17506128 | 14.64 |
Odc1 |
ornithine decarboxylase, structural 1 |
38813 |
0.11 |
chr7_98176524_98176700 | 14.40 |
Gm16938 |
predicted gene, 16938 |
582 |
0.63 |
chr19_24794396_24794754 | 14.38 |
Pgm5 |
phosphoglucomutase 5 |
31497 |
0.16 |
chr14_25687410_25687792 | 14.36 |
Ppif |
peptidylprolyl isomerase F (cyclophilin F) |
6553 |
0.14 |
chr15_83248204_83248526 | 14.31 |
A4galt |
alpha 1,4-galactosyltransferase |
3364 |
0.18 |
chr4_115088603_115088783 | 14.12 |
Pdzk1ip1 |
PDZK1 interacting protein 1 |
15 |
0.97 |
chr8_94974142_94974748 | 14.09 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
306 |
0.84 |
chr7_98175466_98175656 | 14.04 |
Gm16938 |
predicted gene, 16938 |
1633 |
0.28 |
chr6_90712861_90713488 | 14.01 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
3355 |
0.21 |
chr16_92494535_92494840 | 13.91 |
Clic6 |
chloride intracellular channel 6 |
3447 |
0.19 |
chr10_81382117_81382333 | 13.88 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
2203 |
0.09 |
chr13_9107657_9107865 | 13.86 |
Larp4b |
La ribonucleoprotein domain family, member 4B |
13779 |
0.15 |
chr19_53185920_53186082 | 13.63 |
Add3 |
adducin 3 (gamma) |
4405 |
0.18 |
chr10_117663165_117663366 | 13.35 |
Gm25709 |
predicted gene, 25709 |
877 |
0.51 |
chr16_4541512_4542439 | 13.22 |
Srl |
sarcalumenin |
159 |
0.93 |
chr9_43240292_43240713 | 13.09 |
Oaf |
out at first homolog |
591 |
0.68 |
chr7_16781038_16782438 | 12.99 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
370 |
0.78 |
chr4_88893311_88893479 | 12.97 |
Ifne |
interferon epsilon |
13194 |
0.08 |
chr8_93229541_93229729 | 12.97 |
Ces1e |
carboxylesterase 1E |
16 |
0.97 |
chr4_135898801_135898969 | 12.95 |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
3491 |
0.13 |
chr7_100500401_100501097 | 12.93 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr18_62175224_62175380 | 12.91 |
Adrb2 |
adrenergic receptor, beta 2 |
4657 |
0.21 |
chr6_82756785_82756969 | 12.89 |
Gm17034 |
predicted gene 17034 |
7405 |
0.15 |
chr15_25663141_25663443 | 12.87 |
Myo10 |
myosin X |
11218 |
0.18 |
chr11_116575131_116575340 | 12.84 |
Ube2o |
ubiquitin-conjugating enzyme E2O |
6212 |
0.1 |
chr6_86765617_86765810 | 12.71 |
Anxa4 |
annexin A4 |
94 |
0.96 |
chr4_12087867_12088383 | 12.65 |
Tmem67 |
transmembrane protein 67 |
118 |
0.93 |
chr17_80468459_80468787 | 12.61 |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
11346 |
0.21 |
chr16_44016313_44016487 | 12.47 |
Gramd1c |
GRAM domain containing 1C |
36 |
0.97 |
chr19_10203179_10203536 | 12.44 |
Fen1 |
flap structure specific endonuclease 1 |
537 |
0.44 |
chr7_142025987_142026319 | 12.38 |
Mob2 |
MOB kinase activator 2 |
78 |
0.95 |
chr4_46643037_46643443 | 12.37 |
Tbc1d2 |
TBC1 domain family, member 2 |
6969 |
0.2 |
chr16_32509635_32510013 | 12.10 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
10213 |
0.13 |
chr6_113691177_113691368 | 12.08 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
527 |
0.5 |
chr17_48272064_48272554 | 11.98 |
Treml4 |
triggering receptor expressed on myeloid cells-like 4 |
130 |
0.94 |
chr19_24514771_24514953 | 11.94 |
Fam122a |
family with sequence similarity 122, member A |
37506 |
0.14 |
chr5_100572149_100572573 | 11.90 |
Plac8 |
placenta-specific 8 |
116 |
0.95 |
chr5_124236813_124236964 | 11.84 |
Gm42425 |
predicted gene 42425 |
836 |
0.46 |
chr10_80423982_80424244 | 11.79 |
Tcf3 |
transcription factor 3 |
2253 |
0.14 |
chr4_129339534_129339685 | 11.78 |
Zbtb8os |
zinc finger and BTB domain containing 8 opposite strand |
3562 |
0.14 |
chr3_135843797_135843956 | 11.77 |
4933401H06Rik |
RIKEN cDNA 4933401H06 gene |
3607 |
0.18 |
chr7_34313450_34313926 | 11.71 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
137 |
0.94 |
chr1_167374719_167374895 | 11.70 |
Aldh9a1 |
aldehyde dehydrogenase 9, subfamily A1 |
10641 |
0.13 |
chr17_5896167_5896368 | 11.70 |
Gm8376 |
predicted gene 8376 |
42820 |
0.11 |
chr15_99382954_99383108 | 11.68 |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
9851 |
0.09 |
chr9_115218118_115218282 | 11.67 |
Gm27002 |
predicted gene, 27002 |
17802 |
0.15 |
chr12_80813962_80814126 | 11.65 |
Susd6 |
sushi domain containing 6 |
23485 |
0.12 |
chr5_138076362_138076513 | 11.56 |
Zkscan1 |
zinc finger with KRAB and SCAN domains 1 |
8647 |
0.09 |
chr6_113434771_113434951 | 11.53 |
Cidec |
cell death-inducing DFFA-like effector c |
97 |
0.91 |
chr9_123981772_123981964 | 11.49 |
Ccr1l1 |
chemokine (C-C motif) receptor 1-like 1 |
3460 |
0.22 |
chr9_123481263_123481443 | 11.41 |
Limd1 |
LIM domains containing 1 |
743 |
0.65 |
chr7_45677754_45677905 | 11.31 |
Ntn5 |
netrin 5 |
6193 |
0.06 |
chr11_62826279_62826430 | 11.26 |
Trim16 |
tripartite motif-containing 16 |
5885 |
0.13 |
chr7_144747827_144748160 | 11.24 |
Gm44930 |
predicted gene 44930 |
801 |
0.5 |
chr2_52571524_52571970 | 11.22 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
13180 |
0.19 |
chr3_153852379_153852554 | 11.19 |
Asb17os |
ankyrin repeat and SOCS box-containing 17, opposite strand |
42 |
0.95 |
chr7_75830784_75831144 | 11.14 |
Klhl25 |
kelch-like 25 |
17346 |
0.18 |
chr10_42533925_42534363 | 11.14 |
Snx3 |
sorting nexin 3 |
31854 |
0.14 |
chr8_122421630_122421919 | 11.13 |
Il17c |
interleukin 17C |
246 |
0.83 |
chr11_51415145_51415316 | 11.12 |
Col23a1 |
collagen, type XXIII, alpha 1 |
125310 |
0.04 |
chr1_180148615_180148897 | 11.11 |
Gm38331 |
predicted gene, 38331 |
605 |
0.7 |
chr19_53257429_53257580 | 11.09 |
1700001K23Rik |
RIKEN cDNA 1700001K23 gene |
2284 |
0.24 |
chr9_65574847_65575016 | 11.09 |
Plekho2 |
pleckstrin homology domain containing, family O member 2 |
2169 |
0.24 |
chr17_24948381_24948532 | 11.04 |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
11479 |
0.1 |
chr4_150517504_150517732 | 11.04 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
29225 |
0.19 |
chr1_181374683_181374984 | 10.98 |
2900069G24Rik |
RIKEN cDNA 2900069G24 gene |
6345 |
0.17 |
chr14_32022577_32022765 | 10.96 |
Galnt15 |
polypeptide N-acetylgalactosaminyltransferase 15 |
6318 |
0.15 |
chr4_150517961_150518123 | 10.95 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
29649 |
0.18 |
chr10_76664550_76664701 | 10.92 |
Gm35608 |
predicted gene, 35608 |
19807 |
0.14 |
chr6_94203631_94203874 | 10.91 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
79273 |
0.1 |
chr7_115895386_115895546 | 10.91 |
Sox6 |
SRY (sex determining region Y)-box 6 |
35614 |
0.2 |
chr4_129377050_129377794 | 10.88 |
Zbtb8a |
zinc finger and BTB domain containing 8a |
694 |
0.53 |
chr3_115815609_115815956 | 10.84 |
Dph5 |
diphthamide biosynthesis 5 |
72055 |
0.07 |
chr7_123326195_123326356 | 10.82 |
Arhgap17 |
Rho GTPase activating protein 17 |
29685 |
0.16 |
chr19_47432341_47432749 | 10.81 |
Sh3pxd2a |
SH3 and PX domains 2A |
22186 |
0.18 |
chr12_25098272_25099055 | 10.76 |
Id2 |
inhibitor of DNA binding 2 |
1523 |
0.35 |
chr1_86479174_86479713 | 10.75 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr19_56278496_56278647 | 10.74 |
Gm22271 |
predicted gene, 22271 |
926 |
0.6 |
chr9_57978923_57979314 | 10.73 |
Gm17322 |
predicted gene, 17322 |
18923 |
0.13 |
chr4_136180474_136181190 | 10.65 |
E2f2 |
E2F transcription factor 2 |
49 |
0.97 |
chr14_57084344_57084685 | 10.64 |
Gjb2 |
gap junction protein, beta 2 |
20188 |
0.13 |
chr8_105313093_105313575 | 10.61 |
Mir328 |
microRNA 328 |
4874 |
0.06 |
chr4_49549194_49549345 | 10.60 |
Aldob |
aldolase B, fructose-bisphosphate |
277 |
0.88 |
chr2_15164151_15164466 | 10.41 |
Gm13313 |
predicted gene 13313 |
36708 |
0.16 |
chr19_3833522_3833673 | 10.40 |
Gm19209 |
predicted gene, 19209 |
11208 |
0.09 |
chr18_76057499_76057777 | 10.27 |
Zbtb7c |
zinc finger and BTB domain containing 7C |
1820 |
0.38 |
chr7_141117755_141117918 | 10.25 |
Ano9 |
anoctamin 9 |
30 |
0.94 |
chr7_113368807_113369977 | 10.23 |
Btbd10 |
BTB (POZ) domain containing 10 |
0 |
0.97 |
chr7_97747129_97747413 | 10.21 |
Aqp11 |
aquaporin 11 |
8982 |
0.16 |
chr13_49472442_49472674 | 10.20 |
Tes3-ps |
testis derived transcript 3, pseudogene |
20760 |
0.15 |
chr15_98837479_98837647 | 10.19 |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
399 |
0.68 |
chr9_55283587_55283738 | 10.09 |
Nrg4 |
neuregulin 4 |
37 |
0.98 |
chr10_121486384_121486713 | 10.05 |
Gm40787 |
predicted gene, 40787 |
2438 |
0.18 |
chr4_86739363_86739628 | 9.98 |
Dennd4c |
DENN/MADD domain containing 4C |
9060 |
0.22 |
chr12_15653337_15653804 | 9.96 |
Gm4804 |
predicted gene 4804 |
47158 |
0.15 |
chr2_129232031_129232345 | 9.95 |
9830144P21Rik |
RIKEN cDNA 9830144P21 gene |
1609 |
0.21 |
chr14_41007337_41007980 | 9.95 |
Prxl2a |
peroxiredoxin like 2A |
608 |
0.7 |
chr6_127614032_127614649 | 9.93 |
Gm43634 |
predicted gene 43634 |
30100 |
0.15 |
chr10_29313536_29314035 | 9.89 |
Gm46218 |
predicted gene, 46218 |
40 |
0.6 |
chr2_167563411_167563937 | 9.89 |
Gm11476 |
predicted gene 11476 |
10360 |
0.12 |
chr12_99530050_99530394 | 9.89 |
Foxn3 |
forkhead box N3 |
33286 |
0.12 |
chr5_139197301_139197466 | 9.86 |
Sun1 |
Sad1 and UNC84 domain containing 1 |
3254 |
0.18 |
chr4_57947836_57948001 | 9.81 |
Txn1 |
thioredoxin 1 |
8493 |
0.2 |
chr5_24426050_24426729 | 9.81 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
442 |
0.6 |
chr13_61803863_61804026 | 9.80 |
Gm23739 |
predicted gene, 23739 |
304 |
0.47 |
chr7_128854217_128854571 | 9.79 |
Gm25778 |
predicted gene, 25778 |
28047 |
0.15 |
chr11_54025887_54026038 | 9.77 |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
1990 |
0.27 |
chr14_31644829_31645148 | 9.74 |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
3702 |
0.17 |
chr9_111119010_111119184 | 9.70 |
Lrrfip2 |
leucine rich repeat (in FLII) interacting protein 2 |
332 |
0.86 |
chr12_30908463_30908620 | 9.68 |
Acp1 |
acid phosphatase 1, soluble |
3008 |
0.22 |
chr1_165770297_165770472 | 9.66 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
908 |
0.37 |
chr13_109686184_109686430 | 9.64 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
131 |
0.98 |
chr8_46543575_46543796 | 9.63 |
Cenpu |
centromere protein U |
8343 |
0.15 |
chr1_91366227_91366881 | 9.62 |
Erfe |
erythroferrone |
124 |
0.93 |
chr4_35096772_35096992 | 9.61 |
Ifnk |
interferon kappa |
55174 |
0.11 |
chr7_135680390_135680541 | 9.58 |
5830432E09Rik |
RIKEN cDNA 5830432E09 gene |
28151 |
0.12 |
chr9_119469764_119470364 | 9.56 |
Exog |
endo/exonuclease (5'-3'), endonuclease G-like |
25077 |
0.13 |
chr11_101372673_101372965 | 9.56 |
G6pc |
glucose-6-phosphatase, catalytic |
5258 |
0.07 |
chr4_134081547_134081705 | 9.55 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
686 |
0.53 |
chr1_152543572_152543739 | 9.54 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
9389 |
0.26 |
chr7_133698808_133698973 | 9.52 |
Uros |
uroporphyrinogen III synthase |
810 |
0.49 |
chr7_135815808_135816144 | 9.51 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
37706 |
0.12 |
chr5_118488405_118488562 | 9.45 |
Gm15754 |
predicted gene 15754 |
1516 |
0.42 |
chr11_84168651_84168802 | 9.43 |
Gm11437 |
predicted gene 11437 |
1250 |
0.41 |
chr10_95760173_95760361 | 9.42 |
4732465J04Rik |
RIKEN cDNA 4732465J04 gene |
14190 |
0.12 |
chr2_170164248_170164411 | 9.39 |
Zfp217 |
zinc finger protein 217 |
16226 |
0.26 |
chr7_140955310_140955824 | 9.39 |
Gm45717 |
predicted gene 45717 |
370 |
0.44 |
chr11_75403736_75403887 | 9.36 |
Smyd4 |
SET and MYND domain containing 4 |
4202 |
0.11 |
chr5_142651206_142651403 | 9.30 |
Wipi2 |
WD repeat domain, phosphoinositide interacting 2 |
11210 |
0.16 |
chr3_85592177_85592426 | 9.29 |
Gatb |
glutamyl-tRNA(Gln) amidotransferase, subunit B |
18106 |
0.16 |
chr8_69995796_69997172 | 9.27 |
Gatad2a |
GATA zinc finger domain containing 2A |
100 |
0.95 |
chrX_150956475_150956911 | 9.26 |
Gm8424 |
predicted gene 8424 |
30534 |
0.13 |
chr10_83032649_83032841 | 9.23 |
Gm10773 |
predicted gene 10773 |
1050 |
0.56 |
chr6_8752953_8753239 | 9.22 |
Ica1 |
islet cell autoantigen 1 |
5303 |
0.32 |
chr1_154034449_154034624 | 9.20 |
Gm28286 |
predicted gene 28286 |
235 |
0.92 |
chr17_47909349_47909983 | 9.19 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr1_74303603_74304567 | 9.19 |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
35 |
0.94 |
chr18_64325782_64325933 | 9.18 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
7849 |
0.17 |
chr8_11056777_11056930 | 9.18 |
9530052E02Rik |
RIKEN cDNA 9530052E02 gene |
7275 |
0.15 |
chrX_51058858_51059010 | 9.16 |
Gm5387 |
predicted gene 5387 |
14971 |
0.21 |
chr11_79004320_79004485 | 9.15 |
Ksr1 |
kinase suppressor of ras 1 |
16008 |
0.16 |
chr10_41007060_41007223 | 9.15 |
Gm48057 |
predicted gene, 48057 |
28054 |
0.16 |
chr16_41242880_41243222 | 9.12 |
Gm47276 |
predicted gene, 47276 |
25274 |
0.22 |
chr3_9581691_9581938 | 9.10 |
Zfp704 |
zinc finger protein 704 |
16515 |
0.23 |
chr15_22799866_22800017 | 9.05 |
Hnrnpa1l2-ps2 |
heterogeneous nuclear ribonucleoprotein A1-like 2, pseudogene 2 |
85111 |
0.1 |
chr2_60209324_60210635 | 9.04 |
Marchf7 |
membrane associated ring-CH-type finger 7 |
66 |
0.6 |
chr1_184051882_184052065 | 9.01 |
Dusp10 |
dual specificity phosphatase 10 |
17592 |
0.21 |
chr8_122285201_122285360 | 9.01 |
Zfpm1 |
zinc finger protein, multitype 1 |
3139 |
0.2 |
chr5_35771162_35771536 | 8.96 |
Ablim2 |
actin-binding LIM protein 2 |
13298 |
0.18 |
chr16_76532281_76532785 | 8.92 |
Gm30726 |
predicted gene, 30726 |
16262 |
0.21 |
chr5_65348659_65348810 | 8.89 |
Klb |
klotho beta |
326 |
0.82 |
chr17_62749773_62749946 | 8.86 |
Efna5 |
ephrin A5 |
131285 |
0.06 |
chr17_86753909_86754216 | 8.84 |
Epas1 |
endothelial PAS domain protein 1 |
362 |
0.87 |
chr16_12704222_12704505 | 8.84 |
Gm38619 |
predicted gene, 38619 |
5 |
0.99 |
chr5_63821894_63822309 | 8.83 |
0610040J01Rik |
RIKEN cDNA 0610040J01 gene |
9581 |
0.21 |
chr1_184814156_184814307 | 8.83 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
2918 |
0.2 |
chr16_21825593_21825853 | 8.82 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
219 |
0.89 |
chr10_62339575_62340379 | 8.82 |
Hk1os |
hexokinase 1, opposite strand |
279 |
0.71 |
chr2_153153382_153153546 | 8.80 |
Gm25643 |
predicted gene, 25643 |
1549 |
0.32 |
chr8_8238163_8238376 | 8.79 |
A630009H07Rik |
RIKEN cDNA A630009H07 gene |
96808 |
0.07 |
chr8_10856959_10857110 | 8.79 |
Gm32540 |
predicted gene, 32540 |
9152 |
0.12 |
chr18_67667046_67667218 | 8.76 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
23092 |
0.13 |
chr15_22800202_22800353 | 8.74 |
Hnrnpa1l2-ps2 |
heterogeneous nuclear ribonucleoprotein A1-like 2, pseudogene 2 |
85447 |
0.1 |
chr16_5008849_5009001 | 8.74 |
Gm42477 |
predicted gene 42477 |
555 |
0.47 |
chr3_104641030_104641194 | 8.73 |
Gm43581 |
predicted gene 43581 |
1882 |
0.17 |
chr2_153239383_153239670 | 8.71 |
Plagl2 |
pleiomorphic adenoma gene-like 2 |
1618 |
0.26 |
chr7_145092515_145092693 | 8.70 |
Gm45181 |
predicted gene 45181 |
70392 |
0.1 |
chr8_111742224_111742902 | 8.70 |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
1246 |
0.46 |
chr11_119912951_119914125 | 8.70 |
Chmp6 |
charged multivesicular body protein 6 |
97 |
0.95 |
chr6_113717739_113717890 | 8.68 |
Ghrl |
ghrelin |
122 |
0.85 |
chr12_111416956_111417316 | 8.68 |
Exoc3l4 |
exocyst complex component 3-like 4 |
119 |
0.94 |
chr9_67024613_67024806 | 8.68 |
Tpm1 |
tropomyosin 1, alpha |
8116 |
0.18 |
chr18_82474598_82476191 | 8.67 |
Mbp |
myelin basic protein |
24 |
0.98 |
chr18_39397174_39397325 | 8.67 |
Gm15337 |
predicted gene 15337 |
7824 |
0.22 |
chr2_35841028_35841189 | 8.66 |
Gm10829 |
predicted gene 10829 |
3087 |
0.24 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 14.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
4.3 | 12.9 | GO:0001555 | oocyte growth(GO:0001555) |
4.3 | 12.9 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
4.3 | 17.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
4.1 | 12.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
3.9 | 11.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
3.8 | 15.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
3.7 | 11.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
3.5 | 14.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
3.5 | 14.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
3.5 | 14.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
3.4 | 13.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.3 | 13.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
3.1 | 6.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.9 | 11.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
2.6 | 7.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
2.6 | 7.7 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.5 | 9.9 | GO:0002159 | desmosome assembly(GO:0002159) |
2.5 | 7.4 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
2.4 | 7.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.4 | 9.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
2.3 | 15.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.2 | 6.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
2.2 | 6.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
2.2 | 4.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
2.1 | 6.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
2.1 | 4.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
2.1 | 6.3 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
2.0 | 2.0 | GO:0009804 | coumarin metabolic process(GO:0009804) |
2.0 | 6.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.0 | 14.0 | GO:0015825 | L-serine transport(GO:0015825) |
2.0 | 2.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.0 | 2.0 | GO:0061511 | centriole elongation(GO:0061511) |
2.0 | 5.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.9 | 5.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.9 | 9.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.9 | 9.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.9 | 5.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.9 | 11.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.9 | 5.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.9 | 1.9 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.8 | 14.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.8 | 5.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.8 | 3.5 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.8 | 3.5 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.7 | 6.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.7 | 5.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.7 | 1.7 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.7 | 6.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.7 | 6.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.7 | 5.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.6 | 4.9 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
1.6 | 1.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
1.6 | 3.3 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.6 | 14.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.6 | 1.6 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.6 | 4.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.6 | 12.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.6 | 11.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.6 | 4.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.6 | 34.7 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.6 | 4.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.6 | 4.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.6 | 6.2 | GO:0070836 | caveola assembly(GO:0070836) |
1.5 | 6.2 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.5 | 4.6 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.5 | 6.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.5 | 6.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.5 | 3.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.5 | 4.5 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.5 | 6.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.5 | 4.4 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
1.5 | 5.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.5 | 5.9 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.5 | 20.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.5 | 7.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.4 | 4.3 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.4 | 5.7 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.4 | 4.3 | GO:0010288 | response to lead ion(GO:0010288) |
1.4 | 2.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.4 | 4.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.4 | 12.5 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.4 | 4.1 | GO:0008050 | female courtship behavior(GO:0008050) |
1.4 | 4.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.4 | 2.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.4 | 4.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.4 | 1.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
1.4 | 14.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.3 | 13.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.3 | 5.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.3 | 10.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.3 | 8.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.3 | 1.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.3 | 5.3 | GO:1903797 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.3 | 2.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.3 | 9.2 | GO:0001842 | neural fold formation(GO:0001842) |
1.3 | 3.9 | GO:0032439 | endosome localization(GO:0032439) |
1.3 | 3.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.3 | 2.6 | GO:0008228 | opsonization(GO:0008228) |
1.3 | 14.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.3 | 6.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.3 | 3.8 | GO:0040031 | snRNA modification(GO:0040031) |
1.3 | 8.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.3 | 3.8 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.2 | 3.7 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.2 | 3.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.2 | 9.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.2 | 4.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.2 | 4.8 | GO:0032264 | IMP salvage(GO:0032264) |
1.2 | 3.6 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.2 | 2.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
1.2 | 6.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
1.2 | 3.6 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.2 | 4.7 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
1.1 | 3.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.1 | 3.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
1.1 | 5.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.1 | 3.3 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.1 | 11.0 | GO:0018904 | ether metabolic process(GO:0018904) |
1.1 | 4.4 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.1 | 1.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
1.1 | 5.4 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
1.1 | 5.4 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.1 | 2.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.1 | 3.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.1 | 3.2 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.1 | 4.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.1 | 4.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 3.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.1 | 9.6 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.1 | 12.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.1 | 4.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.1 | 3.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.1 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.1 | 3.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.1 | 3.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 3.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.0 | 8.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
1.0 | 3.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.0 | 2.1 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.0 | 7.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.0 | 3.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.0 | 5.2 | GO:0080009 | mRNA methylation(GO:0080009) |
1.0 | 4.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
1.0 | 3.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 2.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
1.0 | 1.0 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.0 | 1.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.0 | 4.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.0 | 9.9 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.0 | 4.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.0 | 4.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.0 | 2.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 3.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.0 | 1.0 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.9 | 1.9 | GO:0014904 | myotube cell development(GO:0014904) |
0.9 | 1.9 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.9 | 4.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.9 | 7.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.9 | 4.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 2.7 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.9 | 2.7 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.9 | 5.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.9 | 2.7 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.9 | 6.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.9 | 8.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.9 | 3.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.9 | 2.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.9 | 4.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.9 | 15.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.9 | 4.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.9 | 2.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.9 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 4.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.9 | 0.9 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.9 | 2.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.9 | 0.9 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.9 | 11.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.9 | 0.9 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.9 | 3.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.8 | 2.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.8 | 10.2 | GO:0051601 | exocyst localization(GO:0051601) |
0.8 | 1.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.8 | 2.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.8 | 14.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.8 | 8.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.8 | 2.5 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.8 | 2.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.8 | 2.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.8 | 3.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.8 | 3.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 1.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.8 | 5.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.8 | 2.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 4.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.8 | 0.8 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.8 | 5.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.8 | 1.6 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.8 | 1.6 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.8 | 3.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.8 | 5.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.8 | 3.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.8 | 10.4 | GO:0050779 | RNA destabilization(GO:0050779) |
0.8 | 0.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.8 | 12.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.8 | 9.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.8 | 3.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.8 | 6.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 3.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.8 | 2.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 1.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 3.1 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
0.8 | 2.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.8 | 5.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.8 | 4.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.8 | 2.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.8 | 2.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.8 | 0.8 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.8 | 1.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.8 | 2.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.8 | 2.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.8 | 3.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.8 | 3.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.8 | 2.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.7 | 1.5 | GO:0070268 | cornification(GO:0070268) |
0.7 | 3.7 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.7 | 0.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 0.7 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.7 | 2.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.7 | 1.5 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.7 | 3.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.7 | 1.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.7 | 1.5 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.7 | 4.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.7 | 1.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.7 | 3.7 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.7 | 3.7 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.7 | 3.7 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.7 | 2.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 3.6 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 7.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.7 | 10.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.7 | 2.9 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.7 | 9.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 3.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.7 | 2.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.7 | 14.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.7 | 2.9 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.7 | 1.4 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 3.6 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.7 | 0.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 2.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.7 | 2.8 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.7 | 2.1 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.7 | 2.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.7 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 1.4 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.7 | 0.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.7 | 2.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 2.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.7 | 4.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 4.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 0.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.7 | 2.1 | GO:0009629 | response to gravity(GO:0009629) |
0.7 | 0.7 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 0.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.7 | 3.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.7 | 7.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.7 | 4.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.7 | 2.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.7 | 1.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.7 | 4.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.7 | 2.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.7 | 0.7 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.7 | 2.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 3.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.7 | 2.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.7 | 2.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.7 | 0.7 | GO:0044351 | macropinocytosis(GO:0044351) |
0.7 | 2.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.7 | 2.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 3.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.7 | 2.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 4.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.7 | 2.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.7 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 3.3 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.7 | 1.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.7 | 0.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.7 | 7.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 | 0.7 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.7 | 2.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.7 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 6.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 3.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.7 | 5.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.7 | 0.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.7 | 4.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.7 | 2.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 1.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.7 | 4.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.6 | 7.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.6 | 1.9 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.6 | 1.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 1.9 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.6 | 1.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.6 | 0.6 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.6 | 1.9 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.6 | 1.9 | GO:0015817 | histidine transport(GO:0015817) |
0.6 | 1.9 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 4.5 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.6 | 1.9 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.6 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.6 | 2.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.6 | 1.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 4.5 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 3.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 0.6 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.6 | 3.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 1.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.6 | 1.9 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.6 | 1.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 1.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.6 | 4.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.6 | 1.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.6 | 1.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 0.6 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.6 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.6 | 1.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.6 | 1.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.6 | 2.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 3.7 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.6 | 2.5 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.6 | 4.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.6 | 5.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 4.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.6 | 2.4 | GO:1900193 | regulation of oocyte maturation(GO:1900193) negative regulation of oocyte maturation(GO:1900194) |
0.6 | 0.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.6 | 0.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.6 | 2.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 1.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 2.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 2.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.6 | 0.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 2.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 1.8 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 4.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 1.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 1.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.6 | 2.4 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.6 | 1.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.6 | 1.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.6 | 0.6 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.6 | 3.0 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.6 | 3.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 2.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.6 | 0.6 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.6 | 1.2 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.6 | 1.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.6 | 2.9 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.6 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 6.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.6 | 1.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.6 | 1.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 4.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.6 | 4.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.6 | 0.6 | GO:0003175 | tricuspid valve development(GO:0003175) |
0.6 | 1.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.6 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 0.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.6 | 2.8 | GO:0000237 | leptotene(GO:0000237) |
0.6 | 1.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.6 | 1.1 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.6 | 1.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.6 | 2.2 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 0.6 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.6 | 7.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.6 | 0.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.6 | 0.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.6 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 3.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.6 | 6.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.6 | 2.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.6 | 1.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.6 | 2.2 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.5 | 2.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 4.9 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 0.5 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.5 | 0.5 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.5 | 1.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.5 | 2.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 1.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 2.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 1.6 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.5 | 2.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 0.5 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.5 | 4.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.5 | 3.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 2.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.5 | 0.5 | GO:0072413 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.5 | 2.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.5 | 2.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.5 | 1.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.5 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 1.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.5 | 0.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.5 | 3.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.5 | 0.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.0 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.5 | 4.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 3.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.5 | 3.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 1.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.5 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.5 | 2.6 | GO:1904970 | brush border assembly(GO:1904970) |
0.5 | 1.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.5 | 1.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.5 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.5 | 8.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.5 | 6.7 | GO:0007099 | centriole replication(GO:0007099) |
0.5 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 1.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 1.5 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.5 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 2.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.5 | 0.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.5 | 2.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.5 | 1.0 | GO:0070293 | renal absorption(GO:0070293) |
0.5 | 1.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.5 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 1.5 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 1.0 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.5 | 2.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.5 | 5.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.5 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.5 | 0.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 3.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.5 | 3.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 1.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 3.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.5 | 1.5 | GO:0090009 | primitive streak formation(GO:0090009) |
0.5 | 2.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.5 | 1.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 1.4 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.5 | 2.9 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.5 | 1.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 4.7 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.5 | 1.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.5 | 1.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.5 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 2.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.5 | 1.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 2.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.5 | 5.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.5 | 6.5 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.5 | 6.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 1.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.5 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 1.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 0.9 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.5 | 3.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.5 | 1.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.5 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.5 | 6.3 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.5 | 1.4 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.5 | 3.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 1.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.4 | 5.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 0.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 0.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 4.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 4.9 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 4.4 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.4 | 0.4 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 0.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.4 | 6.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.4 | 4.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.4 | 1.3 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.4 | 2.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.4 | 3.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.4 | 2.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 2.1 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.4 | 0.9 | GO:1904292 | regulation of ERAD pathway(GO:1904292) positive regulation of ERAD pathway(GO:1904294) |
0.4 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 1.7 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 0.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.4 | 2.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 0.4 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.4 | 0.8 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.4 | 0.4 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.4 | 7.5 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.4 | 1.7 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 0.4 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.4 | 2.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 0.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 2.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 2.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 3.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 0.8 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 0.8 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.4 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 1.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 1.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.4 | 2.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 3.6 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.4 | 3.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 1.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.4 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 1.2 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 0.8 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.4 | 1.6 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 1.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 1.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.4 | 0.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.4 | 1.2 | GO:0009838 | abscission(GO:0009838) |
0.4 | 1.6 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) |
0.4 | 2.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 1.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 0.8 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.4 | 1.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.4 | 1.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.4 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 1.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 0.4 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.4 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 1.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 7.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.4 | 1.5 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.4 | 1.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 1.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 3.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 1.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 1.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.4 | 0.4 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.7 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 3.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 1.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 2.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.4 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.4 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.4 | 0.4 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.4 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.4 | 0.4 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.4 | 0.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 5.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 0.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.4 | 1.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.4 | 0.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.4 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 0.4 | GO:0060440 | trachea formation(GO:0060440) |
0.4 | 1.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 2.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 1.5 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 5.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 1.1 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.4 | 0.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 0.4 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.4 | 1.8 | GO:0019695 | choline metabolic process(GO:0019695) |
0.4 | 0.4 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.4 | 1.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.4 | 0.7 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.4 | 1.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.4 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.4 | 0.4 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.4 | 0.7 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.4 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.4 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 4.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.4 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.4 | 0.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.4 | 0.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 2.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 12.4 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.4 | 17.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.4 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 2.5 | GO:0035561 | regulation of chromatin binding(GO:0035561) positive regulation of chromatin binding(GO:0035563) |
0.4 | 0.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.4 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 0.4 | GO:0032329 | serine transport(GO:0032329) |
0.3 | 2.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.3 | 0.7 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.3 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 1.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.3 | 1.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 2.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 1.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 4.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.3 | 0.7 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 3.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 2.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 1.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 1.4 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 1.4 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.3 | 1.7 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 5.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 4.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.7 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
0.3 | 0.3 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.3 | 4.4 | GO:0051904 | pigment granule transport(GO:0051904) |
0.3 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 2.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 1.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.3 | 2.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 0.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 0.7 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.3 | 4.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.3 | 1.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 1.7 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 1.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.3 | 4.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 0.3 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 0.3 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.3 | 4.9 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 3.3 | GO:0001893 | maternal placenta development(GO:0001893) |
0.3 | 1.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 1.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.3 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 1.0 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.3 | 3.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 4.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 4.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.3 | 1.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.3 | 2.9 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.3 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.3 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 1.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 4.2 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 0.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 2.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.3 | 0.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.3 | 0.3 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.3 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 1.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.3 | 1.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 0.9 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 2.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 2.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 0.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.3 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 1.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.3 | 3.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 9.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 2.2 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 1.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 1.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.3 | 2.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 0.6 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 6.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 0.9 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 1.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 3.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.3 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 0.9 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 6.7 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 1.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 1.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.3 | 0.3 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.3 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 2.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 0.9 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 0.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 0.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.6 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.3 | 0.6 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 0.3 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 11.3 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.3 | 0.3 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.3 | 1.5 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.3 | 3.3 | GO:0002385 | mucosal immune response(GO:0002385) |
0.3 | 0.9 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.3 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 1.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.3 | 0.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 4.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 0.3 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.3 | 1.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.8 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 0.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 1.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.3 | 1.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.3 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.3 | 2.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 1.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 0.9 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 3.5 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 1.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 2.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 0.6 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 1.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 1.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 1.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.3 | 4.3 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.3 | 0.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.3 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.3 | 0.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.3 | GO:0051306 | mitotic sister chromatid separation(GO:0051306) |
0.3 | 2.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.3 | 1.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 3.7 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.3 | 0.8 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.3 | 0.8 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.3 | 0.6 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 0.6 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 0.6 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.3 | 2.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.3 | 1.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 1.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.3 | 1.1 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.3 | 0.8 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.3 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 1.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 1.1 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.1 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.3 | 0.8 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 1.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 3.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 3.5 | GO:0006298 | mismatch repair(GO:0006298) |
0.3 | 1.9 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 0.5 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 1.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 0.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 0.8 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 1.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.5 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.3 | 2.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.3 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.5 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 0.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.3 | 1.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 2.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.3 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 0.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 6.9 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.3 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.3 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.3 | 0.5 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.3 | 1.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 1.8 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.3 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
0.3 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 1.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.5 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.3 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.3 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 0.5 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.3 | 16.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.3 | 1.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.3 | 1.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.3 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 3.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.3 | 1.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.3 | 4.0 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.3 | 2.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 1.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.2 | 0.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.7 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 0.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.7 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 0.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.0 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 0.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.2 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 2.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 2.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 6.3 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.5 | GO:1902308 | peptidyl-serine dephosphorylation(GO:0070262) regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 1.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 1.2 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.7 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.7 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 1.0 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 2.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 1.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 1.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.5 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 1.9 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 13.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.2 | 0.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.2 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 2.1 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 1.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 1.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.5 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 1.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 2.0 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 4.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 1.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 12.5 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.2 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.2 | 0.9 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 2.0 | GO:0035690 | cellular response to drug(GO:0035690) |
0.2 | 0.2 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.2 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.4 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.2 | 0.7 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 1.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.6 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.4 | GO:1903670 | regulation of sprouting angiogenesis(GO:1903670) |
0.2 | 0.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.2 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.4 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.2 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 2.3 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.2 | 5.6 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.8 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 0.8 | GO:0051231 | spindle elongation(GO:0051231) |
0.2 | 0.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 0.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.2 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.2 | 0.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
0.2 | 0.6 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 1.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 0.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 1.2 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 1.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 0.6 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.2 | 1.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 1.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 1.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.2 | 7.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.2 | 0.4 | GO:0033131 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.2 | 3.2 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.2 | 1.4 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 4.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.2 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.2 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.2 | 1.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 0.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 1.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.2 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.2 | 0.2 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.4 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.2 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.2 | 0.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
0.2 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 1.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.2 | 0.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 1.5 | GO:0032967 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.7 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 0.2 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 2.2 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 1.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.1 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 1.1 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.2 | 0.5 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 0.4 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.4 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.2 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.2 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.2 | 0.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 2.8 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.3 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.2 | 1.4 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 1.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 1.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.2 | 0.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.3 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.2 | 0.9 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 0.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.7 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 0.5 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.2 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.8 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.2 | 0.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) |
0.2 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.2 | 0.3 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 33.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.2 | 2.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.3 | GO:0061450 | trophoblast cell migration(GO:0061450) |
0.2 | 0.6 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.2 | 0.6 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.5 | GO:0032094 | response to food(GO:0032094) |
0.2 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.2 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.2 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 2.5 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 0.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.9 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.2 | 1.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 1.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.2 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 1.1 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 2.7 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.2 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.9 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.7 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.1 | 0.9 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 1.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 0.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.7 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 3.4 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.1 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 2.3 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 1.3 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.3 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 1.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 3.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 2.1 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.3 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.7 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 1.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
0.1 | 0.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.1 | GO:0034165 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 1.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 7.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 3.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.1 | 0.7 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.3 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 0.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.4 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 1.1 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 2.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 4.3 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 2.0 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 3.9 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.1 | 0.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.8 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 1.7 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 1.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 1.3 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.8 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.4 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.3 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.5 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.4 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.7 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.8 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 2.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.5 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.7 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 2.1 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.1 | 0.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.9 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.9 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.3 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.1 | 1.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.5 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 3.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.7 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 1.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.1 | 0.8 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 13.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.4 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.1 | 0.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.4 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.7 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.1 | 0.7 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.1 | 0.1 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
0.1 | 0.5 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.1 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.1 | 0.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.1 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 1.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.9 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.1 | 0.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.5 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.6 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.1 | 0.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 1.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.1 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.4 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.1 | 0.3 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.5 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 1.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.6 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 2.0 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0002524 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
0.1 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.3 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.6 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.1 | GO:0051029 | rRNA export from nucleus(GO:0006407) rRNA transport(GO:0051029) |
0.1 | 0.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.5 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.1 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.5 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.1 | 0.2 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.4 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.4 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.1 | GO:0003266 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0048841 | regulation of axon extension involved in axon guidance(GO:0048841) |
0.1 | 0.3 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 1.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:2000104 | negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.1 | 0.2 | GO:0044116 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.8 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.9 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 1.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.1 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 0.9 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 6.5 | GO:0071216 | cellular response to biotic stimulus(GO:0071216) |
0.1 | 0.7 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 1.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0060688 | regulation of morphogenesis of a branching structure(GO:0060688) |
0.1 | 0.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.0 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 1.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.3 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.1 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 1.9 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.1 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.1 | 1.0 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.1 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.1 | 0.1 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.1 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.1 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:2000674 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.1 | 0.1 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.1 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.2 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 1.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 1.0 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) positive regulation of viral release from host cell(GO:1902188) |
0.1 | 1.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 1.0 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
0.1 | 2.3 | GO:1901568 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.1 | 0.1 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.0 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.0 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
0.0 | 0.0 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.0 | 0.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.0 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.3 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.0 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
0.0 | 0.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.3 | GO:0070613 | regulation of protein processing(GO:0070613) |
0.0 | 0.0 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.0 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.9 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.3 | GO:0045582 | positive regulation of T cell differentiation(GO:0045582) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.0 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.4 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.7 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 0.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.1 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.5 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.6 | GO:0016573 | histone acetylation(GO:0016573) |
0.0 | 0.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.1 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.0 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.0 | 0.0 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.5 | GO:0001889 | liver development(GO:0001889) |
0.0 | 1.1 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 8.2 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 0.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.3 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.0 | 0.0 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.0 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.0 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.0 | 0.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.1 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.0 | 0.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.0 | 0.3 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.0 | 0.3 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.3 | GO:0006006 | glucose metabolic process(GO:0006006) |
0.0 | 0.0 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:1903556 | negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.0 | 0.0 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 17.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.1 | 12.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.1 | 24.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.3 | 9.0 | GO:0033269 | internode region of axon(GO:0033269) |
2.1 | 2.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.0 | 5.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.8 | 7.4 | GO:0098536 | deuterosome(GO:0098536) |
1.6 | 22.9 | GO:0000974 | Prp19 complex(GO:0000974) |
1.5 | 6.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.5 | 10.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 5.9 | GO:0042827 | platelet dense granule(GO:0042827) |
1.4 | 4.3 | GO:0005914 | spot adherens junction(GO:0005914) |
1.4 | 11.2 | GO:0005861 | troponin complex(GO:0005861) |
1.4 | 1.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
1.4 | 4.1 | GO:0097513 | myosin II filament(GO:0097513) |
1.3 | 14.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.3 | 3.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.2 | 9.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.2 | 3.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.2 | 9.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.2 | 4.6 | GO:0072487 | MSL complex(GO:0072487) |
1.1 | 4.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 5.6 | GO:0005638 | lamin filament(GO:0005638) |
1.1 | 1.1 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.1 | 4.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.1 | 4.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.1 | 15.0 | GO:0030914 | STAGA complex(GO:0030914) |
1.0 | 5.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 13.0 | GO:0036038 | MKS complex(GO:0036038) |
1.0 | 5.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.9 | 4.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.9 | 7.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 5.6 | GO:0043219 | lateral loop(GO:0043219) |
0.9 | 2.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 8.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.9 | 8.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.9 | 9.9 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.9 | 3.6 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.9 | 3.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 4.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.9 | 6.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.9 | 5.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.9 | 3.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 4.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 4.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.8 | 4.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.8 | 2.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.8 | 2.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.8 | 11.7 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 2.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.7 | 3.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.7 | 9.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.7 | 2.9 | GO:0032021 | NELF complex(GO:0032021) |
0.7 | 1.5 | GO:0005683 | U7 snRNP(GO:0005683) |
0.7 | 10.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 4.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 1.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.7 | 4.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 4.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 3.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 2.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 2.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 2.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.7 | 2.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 2.7 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.7 | 2.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.6 | 3.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 3.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.6 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.6 | 2.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.6 | 7.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 3.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 25.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 4.3 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 44.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 4.8 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.6 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 1.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 3.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 20.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.6 | 5.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 9.3 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 2.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.6 | 1.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 15.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 4.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.6 | 4.5 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 2.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 3.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.6 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 2.2 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 4.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.5 | 3.8 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 6.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.5 | 12.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.5 | 2.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 1.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.5 | 1.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.5 | 5.3 | GO:0034709 | methylosome(GO:0034709) |
0.5 | 2.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.5 | 2.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.5 | 26.8 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 2.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 1.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 3.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.5 | 2.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 3.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.5 | 1.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 12.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.5 | 14.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 2.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.5 | 6.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 4.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.5 | 1.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.5 | 2.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 3.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 3.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.5 | 10.1 | GO:0016592 | mediator complex(GO:0016592) |
0.5 | 0.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 4.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 6.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 7.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.5 | 1.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 1.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 4.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 2.7 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.5 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.4 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 2.7 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.4 | 5.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 14.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.4 | 1.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 2.6 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 1.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 1.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 1.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 5.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 4.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 2.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 5.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 5.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 2.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 3.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 0.4 | GO:0055087 | Ski complex(GO:0055087) |
0.4 | 3.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 5.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
0.4 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 0.4 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 3.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.4 | 10.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 2.5 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 1.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 1.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 0.7 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.4 | 2.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 19.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 1.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 13.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 1.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 5.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 2.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 2.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 1.4 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 15.2 | GO:0001726 | ruffle(GO:0001726) |
0.3 | 2.0 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.3 | 1.3 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 5.0 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 1.0 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 1.7 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 14.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 2.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 0.7 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 6.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 2.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 4.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 8.6 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.6 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 2.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 2.2 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 2.1 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.3 | 1.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 68.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 0.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 2.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 2.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 5.2 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 4.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 2.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 11.3 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 0.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 0.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 4.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 2.2 | GO:0002102 | podosome(GO:0002102) |
0.3 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 2.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 1.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 3.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 8.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.3 | 4.0 | GO:0031672 | A band(GO:0031672) |
0.3 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 1.3 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.8 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.3 | 5.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 3.6 | GO:0000786 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.3 | 2.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 1.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 3.1 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.3 | 1.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.3 | 1.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.3 | 7.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.3 | 0.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 5.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 12.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 3.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 1.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 13.3 | GO:0005903 | brush border(GO:0005903) |
0.2 | 18.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.7 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 1.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 13.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 1.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 4.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.6 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 11.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 14.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 2.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 1.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 49.2 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 0.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 25.1 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 7.9 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 3.2 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 10.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.4 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 58.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 7.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 6.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 0.4 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.2 | 36.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 3.6 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 10.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 233.5 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 1.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 1.4 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.4 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 3.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 268.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.3 | GO:0030894 | replisome(GO:0030894) |
0.2 | 0.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 4.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.2 | 1.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.2 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 6.0 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 3.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.7 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 2.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 7.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 7.1 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 6.4 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.5 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 7.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 2.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.6 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.1 | 0.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 2.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 2.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.1 | 1.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 3.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 4.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 7.5 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.0 | GO:0005901 | caveola(GO:0005901) |
0.1 | 12.3 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.1 | 5.9 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 2.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 41.0 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 31.3 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 5.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 10.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.3 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0031981 | nuclear lumen(GO:0031981) |
0.0 | 1.0 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.0 | 0.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 4.1 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 10.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.1 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:0031519 | PcG protein complex(GO:0031519) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 17.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
3.5 | 13.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.3 | 23.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
3.1 | 9.2 | GO:0030172 | troponin C binding(GO:0030172) |
3.0 | 12.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.9 | 14.4 | GO:0070061 | fructose binding(GO:0070061) |
2.9 | 8.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.7 | 8.2 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.6 | 7.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.5 | 10.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.5 | 7.4 | GO:1990188 | euchromatin binding(GO:1990188) |
2.5 | 9.9 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.5 | 2.5 | GO:0035198 | miRNA binding(GO:0035198) |
2.4 | 12.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
2.3 | 6.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.1 | 4.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.9 | 5.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.8 | 7.3 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.8 | 9.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.8 | 5.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.7 | 1.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.7 | 10.2 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.7 | 16.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 6.4 | GO:0036033 | mediator complex binding(GO:0036033) |
1.6 | 4.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.5 | 10.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.4 | 2.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.4 | 12.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.4 | 5.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.4 | 7.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.4 | 8.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.4 | 5.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 8.0 | GO:0016936 | galactoside binding(GO:0016936) |
1.3 | 1.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.3 | 5.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.3 | 4.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.3 | 7.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.3 | 5.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.3 | 6.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.3 | 3.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.2 | 3.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.2 | 8.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.1 | 5.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.1 | 8.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.1 | 3.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.1 | 4.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.1 | 3.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 3.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.1 | 16.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.1 | 13.0 | GO:0031005 | filamin binding(GO:0031005) |
1.1 | 7.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.1 | 10.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.0 | 4.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.0 | 5.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.0 | 4.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.0 | 3.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.0 | 6.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.0 | 10.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.0 | 8.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.0 | 4.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.0 | 4.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.0 | 2.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.0 | 3.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.0 | 1.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.0 | 2.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 1.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.0 | 3.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.9 | 2.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.9 | 2.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 3.8 | GO:0051425 | PTB domain binding(GO:0051425) |
0.9 | 2.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.9 | 1.9 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.9 | 4.6 | GO:0043559 | insulin binding(GO:0043559) |
0.9 | 3.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.9 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.9 | 1.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 4.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.9 | 5.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.9 | 1.8 | GO:0034618 | arginine binding(GO:0034618) |
0.9 | 4.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.9 | 13.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.9 | 2.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 2.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.8 | 2.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 5.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.8 | 4.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.8 | 4.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 5.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 3.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 5.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.8 | 3.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.8 | 2.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 1.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.8 | 1.6 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 7.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.8 | 1.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.8 | 7.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 1.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.8 | 6.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.8 | 3.1 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 6.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.8 | 3.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.8 | 1.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.8 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 4.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 2.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.7 | 4.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.7 | 6.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.7 | 5.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.7 | 3.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.7 | 13.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 4.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 2.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 2.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.7 | 2.9 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.7 | 10.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.7 | 2.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.7 | 8.6 | GO:0010181 | FMN binding(GO:0010181) |
0.7 | 5.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.7 | 2.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.7 | 39.2 | GO:0005518 | collagen binding(GO:0005518) |
0.7 | 4.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 8.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 2.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.7 | 6.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.7 | 6.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.7 | 6.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.7 | 6.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.7 | 0.7 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.7 | 2.7 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.7 | 2.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 4.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 3.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 2.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 2.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 4.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.7 | 5.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.7 | 1.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.7 | 3.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 3.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 1.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 7.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.6 | 3.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.6 | 1.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.6 | 1.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.6 | 3.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.6 | 1.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 1.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 5.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 2.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 1.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 2.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 1.8 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.6 | 6.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 1.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 1.8 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.6 | 0.6 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.6 | 7.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.6 | 3.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.6 | 5.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 1.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 12.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.6 | 4.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 1.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 0.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) urea channel activity(GO:0015265) |
0.6 | 4.1 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 2.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 1.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 1.2 | GO:0051379 | epinephrine binding(GO:0051379) |
0.6 | 1.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.6 | 2.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 6.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 2.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 2.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.6 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.6 | 2.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 19.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 8.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.6 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 1.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.5 | 17.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.5 | 2.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 2.7 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.5 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 4.9 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 4.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 3.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 2.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.5 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.5 | 3.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.5 | 1.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.5 | 4.3 | GO:0042469 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.5 | 1.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 2.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.5 | 3.2 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.5 | 2.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 0.5 | GO:0035276 | ethanol binding(GO:0035276) |
0.5 | 3.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 2.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.5 | 15.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.5 | 1.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 1.6 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.5 | 1.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 2.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 2.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 7.6 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 9.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.5 | 5.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 5.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.5 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.5 | 2.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.5 | 1.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 5.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.5 | 2.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.5 | 2.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 2.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 2.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 5.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.5 | 3.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 14.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.5 | 4.9 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.5 | 1.5 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 0.5 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.5 | 1.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.5 | 7.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.5 | 7.7 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 2.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 4.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.5 | 9.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.5 | 13.7 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.5 | 1.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.5 | 0.9 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.5 | 2.3 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.5 | 2.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.5 | 1.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 1.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 3.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 2.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 2.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.4 | 8.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 0.9 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 1.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 1.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 1.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 1.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 7.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.4 | 5.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 3.5 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 1.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 3.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 0.4 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.4 | 1.7 | GO:0005534 | galactose binding(GO:0005534) |
0.4 | 1.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 1.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 1.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 4.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 2.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 5.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.4 | 6.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 10.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 11.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 1.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 2.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 2.0 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 1.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.4 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 3.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 3.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 4.7 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 1.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 1.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.2 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 4.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 2.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 4.2 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.4 | 18.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.4 | 8.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 11.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.4 | 1.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.4 | 1.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 1.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 3.0 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 7.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 1.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.4 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.4 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 9.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 13.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 1.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 2.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 1.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.4 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 11.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 5.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 3.9 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 7.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.4 | 0.4 | GO:0016436 | rRNA methyltransferase activity(GO:0008649) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.4 | 5.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 0.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.4 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 2.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 2.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 1.0 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 2.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 2.4 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.3 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 5.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 1.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 2.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 3.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 8.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 2.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 0.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.7 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 4.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 1.9 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 1.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 4.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 15.3 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 35.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 9.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 11.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 4.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 2.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 5.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 2.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 1.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 3.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 3.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 5.4 | GO:0045502 | dynein binding(GO:0045502) |
0.3 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 7.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 2.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.6 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 4.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 0.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 1.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 0.9 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 3.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 3.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 2.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.3 | 2.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 0.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 2.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 5.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 4.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.3 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 1.7 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.3 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 3.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.3 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 1.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 0.6 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.3 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.3 | 15.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 4.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.9 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.3 | 1.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 16.3 | GO:0060090 | binding, bridging(GO:0060090) |
0.3 | 3.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 13.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 4.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.3 | 2.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 0.5 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 0.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 2.9 | GO:0048038 | quinone binding(GO:0048038) |
0.3 | 1.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.3 | 0.5 | GO:0018568 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 1.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 1.5 | GO:0050543 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.3 | 0.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.3 | 0.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 1.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 4.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 5.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.3 | 1.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.3 | 19.9 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.3 | 0.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 1.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 0.5 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 2.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 2.7 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 6.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.7 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 4.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 2.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 8.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 2.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 3.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 1.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 3.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.2 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 5.4 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 0.2 | GO:0060229 | lipase activator activity(GO:0060229) |
0.2 | 4.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.2 | 0.7 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.9 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) glycine:sodium symporter activity(GO:0015375) |
0.2 | 1.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 12.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 1.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 9.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 6.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 3.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 18.2 | GO:0020037 | heme binding(GO:0020037) |
0.2 | 0.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 3.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 1.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 3.4 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 1.0 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 2.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.2 | 2.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 17.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 4.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 5.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 1.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 0.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.2 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 15.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.2 | 7.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 0.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 28.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 16.9 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.2 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 3.1 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.3 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.2 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 2.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.2 | 28.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.2 | 1.4 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.2 | 0.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 3.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 1.4 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 3.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 2.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0018636 | phenanthrene 9,10-monooxygenase activity(GO:0018636) |
0.1 | 0.4 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
0.1 | 1.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.6 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.9 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.3 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 16.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.1 | 1.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 1.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 2.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 4.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 3.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 14.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 6.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 1.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.5 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.1 | 0.9 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.6 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 6.0 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 0.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.5 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 1.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 5.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 4.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.3 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 4.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 12.8 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 1.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 2.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 5.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 3.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.8 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.1 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 13.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 5.6 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 5.5 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 5.5 | GO:0016791 | phosphatase activity(GO:0016791) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 2.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.1 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.6 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.7 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 12.5 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 11.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 1.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 9.5 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 2.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.0 | 0.1 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.0 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 4.2 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 2.1 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.6 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0097617 | annealing activity(GO:0097617) |
0.0 | 0.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.0 | 0.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.0 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.2 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 1.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.2 | GO:0019840 | isoprenoid binding(GO:0019840) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.0 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.7 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 1.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 23.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 1.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
1.1 | 35.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.9 | 34.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.9 | 6.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.9 | 22.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.9 | 1.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 14.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 10.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 10.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.8 | 32.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 14.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.7 | 11.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 13.1 | PID EPO PATHWAY | EPO signaling pathway |
0.7 | 1.3 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 12.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 9.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.6 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 6.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 28.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 3.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 2.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.6 | 33.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 21.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.6 | 8.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 27.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.6 | 5.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 6.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.6 | 12.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.6 | 3.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 4.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 20.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.5 | 5.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 5.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 17.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.5 | 11.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.5 | 18.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 8.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 2.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.5 | 4.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 4.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 0.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 2.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 2.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 1.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 9.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.4 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 1.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 6.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 9.9 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 2.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 2.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 10.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 3.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 6.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 0.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 18.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 4.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 3.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 3.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 6.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 2.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.3 | 4.6 | PID ATM PATHWAY | ATM pathway |
0.3 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 35.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 6.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 2.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 2.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 5.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 2.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 1.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 6.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 5.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 2.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 16.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 5.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 4.0 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 42.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 7.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 6.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 4.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 2.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.7 | 1.7 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.7 | 16.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.5 | 17.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.3 | 13.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.3 | 13.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 26.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.2 | 11.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.2 | 11.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.2 | 2.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.1 | 27.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.1 | 2.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.1 | 17.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.0 | 11.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.0 | 7.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 1.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.9 | 10.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.9 | 1.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.9 | 9.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.9 | 13.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.9 | 4.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 4.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.8 | 13.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 4.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.7 | 10.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.7 | 3.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.7 | 2.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 0.7 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.7 | 12.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.7 | 5.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.6 | 2.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.6 | 7.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 5.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.6 | 10.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 13.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 28.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 12.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.6 | 8.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.6 | 9.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.6 | 5.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 18.8 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.6 | 9.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 3.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 3.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 13.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 8.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 3.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.5 | 5.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.5 | 8.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.5 | 13.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.5 | 10.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.5 | 3.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 8.5 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.5 | 6.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 7.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.5 | 5.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 3.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 1.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.5 | 2.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 5.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 1.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.5 | 6.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 12.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 2.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 2.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 31.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 10.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 7.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 5.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.4 | 3.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 14.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 0.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 4.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 8.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.4 | 0.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.4 | 3.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.4 | 5.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.4 | 6.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 4.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.4 | 2.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 6.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 5.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 6.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 9.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 11.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 4.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 4.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 5.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.4 | 6.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 9.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 12.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 3.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 9.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 5.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 1.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 13.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 7.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 3.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 3.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 3.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.3 | 5.0 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 1.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 7.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 4.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 4.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 2.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 1.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 0.3 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.3 | 3.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 8.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 3.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 1.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 1.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 5.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 1.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 0.6 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 12.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 3.7 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 0.6 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.3 | 2.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 1.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 3.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.3 | 24.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 2.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 14.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 2.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 1.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 1.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 5.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 5.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 1.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 4.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 0.7 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
0.2 | 1.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 5.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 7.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 3.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 4.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 7.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 0.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.2 | 0.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 3.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 3.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 4.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 1.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 4.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 0.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 9.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 20.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 4.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 3.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 3.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 9.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 8.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 7.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 6.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 4.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.6 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.1 | 2.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.5 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 9.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 6.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.6 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.3 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 0.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.4 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 0.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 2.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 2.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |